Not Yet Available

Would you like to receive an email notification when this part becomes available?

* indicates required


 
 
CALIFORNIA PROPOSITION 65 CERTIFICATE OF COMPLIANCE


Company: National Products Inc.
Address: 8410 Dallas Ave S.
Seattle, Wa. 98108

Contact person: Chad Remmers
Title: COO
E-mail: chadr@rammount.com
Telephone: 206-763-8361

P/N: All Products Produced

This letter is to assure that the above-mentioned product(s) made from the above-mentioned company do not contain any of the following California Proposition 65 chemicals, or if a threshold is stated, then all before mentioned parts are below the required levels.
 
Chemical Type of Toxicity Listing Mechanism CAS No. Date Listed NSRL or MADL (µg/day)a
A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole) cancer AB 26148-68-5 1-Jan-90 2
Acetaldehyde cancer SQE 75-07-0 1-Apr-88 90 (inhalation)
Acetamide cancer AB 60-35-5 1-Jan-90 10
Acetazolamide developmental FR 59-66-5 20-Aug-99
Acetochlor cancer SQE 34256-82-1 1-Jan-89
Acetohydroxamic acid developmental FR 546-88-3 1-Apr-90
2-Acetylaminofluorene cancer SQE 53-96-3 1-Jul-87 0.2
Acifluorfen sodium cancer AB 62476-59-9 1-Jan-90
Acrylamide cancer AB 79-06-1 1-Jan-90 0.2
Acrylamide developmental, male AB 79-06-1 25-Feb-11 140
Acrylonitrile cancer FR 107-13-1 1-Jul-87 0.7
Actinomycin D [Basis for listing changed effective February 22, 2013] cancer FR 50-76-0 1-Oct-89 0.00008
Actinomycin D developmental FR 50-76-0 1-Oct-92
AF-2;[2-(2-furyl)-3-(5-nitro-2-furyl)]acrylamide cancer SQE 3688-53-7 1-Jul-87 3
Aflatoxins cancer SQE --- 1-Jan-88
Alachlor cancer SQE 15972-60-8 1-Jan-89
Alcoholic beverages, when associated with alcohol abuse cancer SQE --- 1-Jul-88
Aldrin cancer SQE 309-00-2 1-Jul-88 0.04
All-trans retinoic acid developmental SQE 302-79-4 1-Jan-89
Allyl chloride Delisted October 29, 1999 [Click here for the basis for delisting] cancer AB 107-05-1 1-Jan-90
Alprazolam developmental FR 28981-97-7 1-Jul-90
Altretamine developmental, male FR 645-05-6 20-Aug-99
Amantadine hydrochloride developmental FR 665-66-7 27-Feb-01
Amikacin sulfate developmental FR 39831-55-5 1-Jul-90
2-Aminoanthraquinone cancer LC 117-79-3 1-Oct-89 20
p-Aminoazobenzene cancer AB 60-09-3 1-Jan-90
o-Aminoazotoluene cancer SQE 97-56-3 1-Jul-87 0.2
4-Aminobiphenyl (4-aminodiphenyl) cancer LC 92-67-1 27-Feb-87 0.03
1-Amino-2,4-dibromoanthraquinone cancer AB 81-49-2 26-Aug-97
3-Amino-9-ethylcarbazole hydrochloride cancer SQE 6109-97-3 1-Jul-89 9
2-Aminofluorene cancer SQE 153-78-6 29-Jan-99
Aminoglutethimide developmental FR 125-84-8 1-Jul-90
Aminoglycosides developmental FR --- 1-Oct-92
1-Amino-2-methylanthraquinone cancer LC 82-28-0 1-Oct-89 5
2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole cancer SQE 712-68-5 1-Jul-87 0.04
4-Amino-2-nitrophenol cancer SQE 119-34-6 29-Jan-99
Aminopterin developmental, female SQE 54-62-6 1-Jul-87
Amiodarone hydrochloride developmental, female, male FR 19774-82-4 26-Aug-97
Amitraz developmental AB 33089-61-1 30-Mar-99
Amitrole cancer SQE 61-82-5 1-Jul-87 0.7
Amoxapine developmental FR 14028-44-5 15-May-98
Amsacrine cancer LC 51264-14-3 7-Aug-09
tert-Amyl methyl ether Delisted December 13, 2013 [Click here for the basis for delisting] developmental LC 994-05-8 18-Dec-09
Anabolic steroids female, male FR --- 1-Apr-90
Analgesic mixtures containing Phenacetin cancer LC --- 27-Feb-87
Androstenedione cancer AB 63-05-8 3-May-11
Angiotensin converting enzyme (ACE) inhibitors developmental FR --- 1-Oct-92
Aniline cancer AB 62-53-3 1-Jan-90 100
Aniline hydrochloride cancer AB 142-04-1 15-May-98
o-Anisidine cancer SQE 90-04-0 1-Jul-87 5
o-Anisidine hydrochloride cancer SQE 134-29-2 1-Jul-87 7
Anisindione developmental FR 117-37-3 1-Oct-92
Anthraquinone cancer AB 84-65-1 28-Sep-07
Antimony oxide (Antimony trioxide) cancer AB 1309-64-4 1-Oct-90
Aramite cancer SQE 140-57-8 1-Jul-87 20
Areca nut cancer LC --- 3-Feb-06
Aristolochic acids cancer LC --- 9-Jul-04
Arsenic (inorganic arsenic compounds) cancer LC -- 27-Feb-87 0.06 (inhalation) 10 (except inhalation)
Arsenic (inorganic oxides) developmental SQE --- 1-May-97
Asbestos cancer LC 1332-21-4 27-Feb-87 100 fibers/day (inhalation)
Aspirin (NOTE: It is especially important not to use aspirin during the last three months of pregnancy, unless specifically directed to do so by a physician because it may cause problems in the unborn child or complications during delivery.) developmental, female SQE 50-78-2 1-Jul-90
Atenolol developmental FR 29122-68-7 26-Aug-97
Auramine cancer SQE 492-80-8 1-Jul-87 0.8
Auranofin developmental FR 34031-32-8 29-Jan-99
Avermectin B1 (Abamectin) developmental AB 71751-41-2 3-Dec-10 4.4
Azacitidine cancer AB 320-67-2 1-Jan-92
Azaserine cancer SQE 115-02-6 1-Jul-87 0.06
Azathioprine cancer LC 446-86-6 27-Feb-87 0.4
Azathioprine developmental FR 446-86-6 1-Sep-96
Azobenzene cancer AB 103-33-3 1-Jan-90 6
Barbiturates developmental FR --- 1-Oct-92
Beclomethasone dipropionate developmental FR 5534-09-8 15-May-98
Benomyl developmental, male SQE 17804-35-2 1-Jul-91
Benthiavalicarb-isopropyl cancer AB 177406-68-7 1-Jul-08
Benz[a]anthracene cancer SQE 56-55-3 1-Jul-87 0.033 (oral)
Benzene cancer LC 71-43-2 27-Feb-87 6.4 (oral) 13 (inhalation)
Benzene developmental, male SQE 71-43-2 26-Dec-97 24 (oral) 49 (inhalation)
Benzidine [and its salts] cancer LC 92-87-5 27-Feb-87 0.001
Benzidine-based dyes cancer FR --- 1-Oct-92
Benzodiazepines developmental FR --- 1-Oct-92
Benzo[b]fluoranthene cancer SQE 205-99-2 1-Jul-87 0.096 (oral)
Benzo[j]fluoranthene cancer SQE 205-82-3 1-Jul-87 0.11 (oral)
Benzo[k]fluoranthene cancer SQE 207-08-9 1-Jul-87
Benzofuran cancer AB 271-89-6 1-Oct-90 1.1
Benzophenone cancer LC 119-61-9 22-Jun-12
Benzo[a]pyrene cancer SQE 50-32-8 1-Jul-87 0.06
Benzotrichloride cancer SQE 98-07-7 1-Jul-87
Benzphetamine hydrochloride developmental FR 5411-22-3 1-Apr-90
Benzyl chloride cancer AB 100-44-7 1-Jan-90 4
Benzyl violet 4B cancer SQE 1694-09-3 1-Jul-87 30
Beryllium and beryllium compounds cancer SQE --- 1-Oct-87
Beryllium 0.1
Beryllium oxide 0.1
Beryllium sulfate 0.0002
Betel quid with tobacco cancer AB --- 1-Jan-90
Betel quid without tobacco cancer LC --- 3-Feb-06
2,2-Bis(bromomethyl)-1,3-propanediol cancer AB 3296-90-0 1-May-96
Bis(2-chloroethyl)ether cancer SQE 111-44-4 1-Apr-88 0.3
N,N-Bis(2-chloroethyl)-2-naphthylamine (Chlornapazine) cancer LC 494-03-1 27-Feb-87
Bischloroethyl nitrosourea (BCNU) (Carmustine) cancer SQE 154-93-8 1-Jul-87
Bischloroethyl nitrosourea (BCNU) (Carmustine) developmental FR 154-93-8 1-Jul-90
Bis(chloromethyl)ether cancer LC 542-88-1 27-Feb-87 0.02
Bis(2-chloro-1-methylethyl)ether, technical grade cancer SQE --- 29-Oct-99
Bisphenol A (BPA) Delisted April 19, 2013 [Click here for the basis for delisting] developmental AB 80-05-7 11-Apr-13
Bitumens, extracts of steam-refined and air refined cancer AB --- 1-Jan-90
Bracken fern cancer AB --- 1-Jan-90
Bromacil lithium salt developmental AB 53404-19-6 18-May-99
Bromacil lithium salt male SQE 53404-19-6 17-Jan-03
Bromate cancer AB 15541-45-4 31-May-02
Bromochloroacetic acid cancer AB 5589-96-8 6-Apr-10
Bromodichloromethane cancer AB 75-27-4 1-Jan-90 5
Bromoethane cancer AB 74-96-4 22-Dec-00 96
Bromoform cancer AB 75-25-2 1-Apr-91 64
1-Bromopropane (1-BP) developmental, female, male AB 106-94-5 7-Dec-04
2-Bromopropane (2-BP) female, male AB 75-26-3 31-May-05
Bromoxynil developmental FR 1689-84-5 1-Oct-90
Bromoxynil octanoate developmental AB 1689-99-2 18-May-99
Butabarbital sodium developmental FR 143-81-7 1-Oct-92
1,3-Butadiene cancer SQE 106-99-0 1-Apr-88 0.4
1,3-Butadiene developmental, female, male AB 106-99-0 16-Apr-04
1,4-Butanediol dimethanesulfonate (Busulfan) cancer LC 55-98-1 27-Feb-87
1,4-Butanediol dimethanesulfonate (Busulfan) developmental SQE 55-98-1 1-Jan-89
Butylated hydroxyanisole cancer AB 25013-16-5 1-Jan-90 4000
Butyl benzyl phthalate (BBP)d developmental AB 85-68-7 2-Dec-05 1200 (oral)
n-Butyl glycidyl ether Delisted April 4, 2014 [Click here for the basis for delisting] male LC 2426-08-6 7-Aug-09
beta-Butyrolactone cancer SQE 3068-88-0 1-Jul-87 0.7
Cacodylic acid cancer AB 75-60-5 1-May-96
Cadmium developmental, male SQE --- 1-May-97 4.1 (oral)
Cadmium and cadmium compounds cancer SQE --- 1-Oct-87
Cadmium 0.05 (inhalation)
Caffeic acid cancer AB 331-39-5 1-Oct-94
Captafol cancer SQE 2425-06-1 1-Oct-88 5
Captan cancer AB 133-06-2 1-Jan-90 300
Carbamazepine developmental FR 298-46-4 29-Jan-99
Carbaryl cancer AB 63-25-2 5-Feb-10
Carbaryl [Basis for listing changed effective December 27, 2013] developmental, female, male AB 63-25-2 7-Aug-09
Carbazole cancer AB 86-74-8 1-May-96 4.1
Carbon black (airborne, unbound particles of respirable size) cancer AB 1333-86-4 21-Feb-03
Carbon disulfide developmental, female, male SQE 75-15-0 1-Jul-89
Carbon monoxide developmental SQE 630-08-0 1-Jul-89
Carbon tetrachloride cancer SQE 56-23-5 1-Oct-87 5
Carbon-black extracts cancer AB --- 1-Jan-90
Carboplatin developmental FR 41575-94-4 1-Jul-90
N-Carboxymethyl-N-nitrosourea cancer SQE 60391-92-6 25-Jan-02 0.7
Catechol cancer AB 120-80-9 15-Jul-03
Ceramic fibers (airborne particles of respirable size) cancer AB --- 1-Jul-90
Certain combined chemotherapy for lymphomas cancer LC --- 27-Feb-87
Chenodiol developmental FR 474-25-9 1-Apr-90
Chloral cancer LC 75-87-6 13-Sep-13
Chloral hydrate cancer LC 302-17-0 13-Sep-13
Chlorambucil cancer LC 305-03-3 27-Feb-87 0.002
Chlorambucil developmental SQE 305-03-3 1-Jan-89
Chloramphenicol Delisted January 4, 2013 [Click here for the basis for delisting] cancer LC 56-75-7 1-Oct-89
Chloramphenicol sodium succinate cancer FR 982-57-0 27-Sep-13
Chlorcyclizine hydrochloride developmental FR 1620-21-9 1-Jul-87
Chlordane cancer SQE 57-74-9 1-Jul-88 0.5
Chlordecone (Kepone) cancer SQE 143-50-0 1-Jan-88 0.04
Chlordecone (Kepone) developmental SQE 143-50-0 1-Jan-89
Chlordiazepoxide developmental FR 58-25-3 1-Jan-92
Chlordiazepoxide hydrochloride developmental FR 438-41-5 1-Jan-92
Chlordimeform cancer SQE 6164-98-3 1-Jan-89
Chlorendic acid cancer SQE 115-28-6 1-Jul-89 8
Chlorinated paraffins (Average chain length, C12;approximately 60 percent chlorine by weight) cancer SQE 108171-26-2 1-Jul-89 8
p-Chloroaniline cancer AB 106-47-8 1-Oct-94 1.5
p-Chloroaniline hydrochloride cancer AB 20265-96-7 15-May-98 1.9
Chlorodibromomethane Delisted October 29, 1999 [Click here for the basis for delisting] cancer AB 124-48-1 1-Jan-90
Chloroethane (Ethyl chloride) cancer AB 75-00-3 1-Jul-90 150
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine) cancer SQE 13010-47-4 1-Jan-88
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine) developmental FR 13010-47-4 1-Jul-90
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) cancer SQE 13909-09-6 1-Oct-88
Chloroform cancer SQE 67-66-3 1-Oct-87 20 (oral) 40 (inhalation)
Chloroform developmental LC 67-66-3 7-Aug-09
Chloromethyl methyl ether (technical grade) cancer LC 107-30-2 27-Feb-87 0.3
3-Chloro-2-methylpropene cancer SQE 563-47-3 1-Jul-89 5
1-Chloro-4-nitrobenzene cancer SQE 100-00-5 29-Oct-99
4-Chloro-o-phenylenediamine cancer SQE 95-83-0 1-Jan-88 40
Chloroprene cancer AB 126-99-8 2-Jun-00
2-Chloropropionic acid [Basis for listing changed effective December 20, 2013] male SQE 598-78-7 7-Aug-09
Chlorothalonil cancer SQE 1897-45-6 1-Jan-89 41
p-Chloro-o-toluidine cancer AB 95-69-2 1-Jan-90 3
p-Chloro-o-toluidine, strong acid salts of cancer AB --- 15-May-98
p-Chloro-o-toluidine, hydrochloride 3.3
5-Chloro-o-toluidine and its strong acid salts cancer SQE --- 24-Oct-97
Chlorotrianisene cancer FR 569-57-3 1-Sep-96
Chlorozotocin cancer AB 54749-90-5 1-Jan-92 0.003
Chlorsulfuron Delisted June 6, 2014 [Click here for the basis for delisting] developmental, female, male AB 64902-72-3 14-May-99
Chromium (hexavalent compounds) cancer LC --- 27-Feb-87 0.001 (inhalation)
Chromium (hexavalent compounds) developmental, female, male SQE --- 19-Dec-08 8.2 (oral)
Chrysene cancer AB 218-01-9 1-Jan-90 0.35 (oral)
C.I. Acid Red 114 cancer AB 6459-94-5 1-Jul-92
C.I. Basic Red 9 monohydrochloride cancer SQE 569-61-9 1-Jul-89 3
C.I. Direct Blue 15 cancer AB 2429-74-5 26-Aug-97
C.I. Direct Blue 218 cancer AB 28407-37-6 26-Aug-97 50
C.I. Disperse Yellow 3 cancer SQE 2832-40-8 8-Feb-13
C.I. Solvent Yellow 14 cancer AB 842-07-9 15-May-98
Ciclosporin (Cyclosporin A; Cyclosporine) cancer AB 59865-13-3; 79217-60-0 1-Jan-92
Cidofovir cancer, developmental, female, male FR 113852-37-2 29-Jan-99
Cinnamyl anthranilate cancer SQE 87-29-6 1-Jul-89 200
Cisplatin cancer SQE 15663-27-1 1-Oct-88
Citrus Red No. 2 cancer LC 6358-53-8 1-Oct-89
Cladribine developmental FR 4291-63-8 1-Sep-96
Clarithromycin developmental FR 81103-11-9 1-May-97
Clobetasol propionate developmental, female FR 25122-46-7 15-May-98
Clofibrate cancer FR 637-07-0 1-Sep-96
Clomiphene citrate cancer FR 50-41-9 24-May-13
Clomiphene citrate developmental FR 50-41-9 1-Apr-90
Clorazepate dipotassium developmental FR 57109-90-7 1-Oct-92
Cobalt metal powder cancer AB 7440-48-4 1-Jul-92
Cobalt [II] oxide cancer AB 1307-96-6 1-Jul-92
Cobalt sulfate cancer LC 10124-43-3 20-May-05
Cobalt sulfate heptahydrate cancer AB 10026-24-1 2-Jun-00
Cocaine developmental, female SQE 50-36-2 1-Jul-89
Coconut oil diethanolamine condensate (cocamide diethanolamine) cancer LC 68603-42-9 22-Jun-12
Codeine phosphate developmental FR 52-28-8 15-May-98
Coke oven emissions cancer LC --- 27-Feb-87 0.3
Colchicine developmental, male FR 64-86-8 1-Oct-92
Conjugated estrogens cancer LC --- 27-Feb-87
Conjugated estrogens developmental FR --- 1-Apr-90
Creosotes cancer SQE --- 1-Oct-88
p-Cresidine cancer SQE 120-71-8 1-Jan-88 5
Cumene cancer AB 98-82-8 6-Apr-10
Cupferron cancer SQE 135-20-6 1-Jan-88 3
Cyanazine developmental FR 21725-46-2 1-Apr-90
Cycasin cancer SQE 14901-08-7 1-Jan-88
Cycloate developmental AB 1134-23-2 19-Mar-99
Cyclohexanol Delisted January 25, 2002 [Click here for the basis for delisting] male AB 108-93-0 6-Nov-98
Cycloheximide developmental FR 66-81-9 1-Jan-89
Cyclopenta[cd]pyrene cancer LC 27208-37-3 29-Apr-11
Cyclophosphamide (anhydrous) cancer LC 50-18-0 27-Feb-87 1
Cyclophosphamide (anhydrous) developmental, female, male SQE - developmental FR - female, male 50-18-0 1-Jan-89
Cyclophosphamide (hydrated) cancer LC 6055-19-2 27-Feb-87 1
Cyclophosphamide (hydrated) developmental, female, male SQE - developmental FR - female, male 6055-19-2 1-Jan-89
Cyhexatin developmental FR 13121-70-5 1-Jan-89
Cytarabine developmental SQE 147-94-4 1-Jan-89
Cytembena cancer AB 21739-91-3 15-May-98
D&C Orange No. 17 cancer AB 3468-63-1 1-Jul-90
D&C Red No. 8 cancer AB 2092-56-0 1-Oct-90
D&C Red No. 9 cancer AB 5160-02-1 1-Jul-90 100
D&C Red No. 19 cancer AB 81-88-9 1-Jul-90
Dacarbazine cancer SQE 4342-03-4 1-Jan-88 0.01
Dacarbazine developmental FR 4342-03-4 29-Jan-99
Daminozide cancer AB 1596-84-5 1-Jan-90 40
Danazol developmental FR 17230-88-5 1-Apr-90
Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone) cancer AB 117-10-2 1-Jan-92 9
Daunomycin cancer SQE 20830-81-3 1-Jan-88
Daunorubicin hydrochloride developmental FR 23541-50-6 1-Jul-90
2,4-D butyric acid [Click here for the basis for the removal of developmental endpoint, effective June 22, 2001] developmental, male AB 94-82-6 18-Jun-99 910
DDD (Dichlorodiphenyl-dichloroethane) cancer SQE 72-54-8 1-Jan-89 2 (DDT, DDE, DDD in combination)
DDE (Dichlorodiphenyl-dichloroethylene) cancer SQE 72-55-9 1-Jan-89 2 (DDT, DDE, DDD in combination)
DDT (Dichlorodiphenyl-trichloroethane) cancer SQE 50-29-3 1-Oct-87 2 (DDT, DDE, DDD in combination)
o,p'-DDT developmental, female, male AB 789-02-6 15-May-98
p,p'-DDT developmental, female, male AB 50-29-3 15-May-98
DDVP (Dichlorvos) cancer SQE 62-73-7 1-Jan-89 2
2,4-DP (dichloroprop) Delisted January 25, 2002 [Click here for the basis for delisting] developmental AB 120-36-5 27-Apr-99
Demeclocycline hydrochloride (internal use) developmental FR 64-73-3 1-Jan-92
N,N'-Diacetylbenzidine cancer LC 613-35-4 1-Oct-89
2,4-Diaminoanisole cancer FR 615-05-4 1-Oct-90 30
2,4-Diaminoanisole sulfate cancer SQE 39156-41-7 1-Jan-88 50
4,4'-Diaminodiphenyl ether (4,4'-Oxydianiline) cancer SQE 101-80-4 1-Jan-88 5
2,4-Diaminotoluene cancer SQE 95-80-7 1-Jan-88 0.2
Diaminotoluene (mixed) cancer AB --- 1-Jan-90
Diazepam developmental FR 439-14-5 1-Jan-92
Diazoaminobenzene cancer LC 136-35-6 20-May-05
Diazoxide developmental FR 364-98-7 27-Feb-01
Dibenz[a,h]acridine cancer SQE 226-36-8 1-Jan-88
Dibenz[a,j]acridine cancer SQE 224-42-0 1-Jan-88
Dibenz[a,h]anthracene cancer SQE 53-70-3 1-Jan-88 0.2
7H-Dibenzo[c,g]carbazole cancer SQE 194-59-2 1-Jan-88 0.0030 (oral)
Dibenzo[a,e]pyrene cancer SQE 192-65-4 1-Jan-88
Dibenzo[a,h]pyrene cancer SQE 189-64-0 1-Jan-88 0.0054 (oral)
Dibenzo[a,i]pyrene cancer SQE 189-55-9 1-Jan-88 0.0050 (oral)
Dibenzo[a,l]pyrene cancer SQE 191-30-0 1-Jan-88
Dibromoacetic acid cancer AB 631-64-1 17-Jun-08
Dibromoacetonitrile cancer AB 3252-43-5 3-May-11
1,2-Dibromo-3-chloropropane (DBCP) cancer FR 96-12-8 1-Jul-87 0.1
1,2-Dibromo-3-chloropropane (DBCP) [Basis for listing changed effective November 22, 2013] male FR 96-12-8 27-Feb-87 3.1 (oral) 4.3 (inhalation)
2,3-Dibromo-1-propanol cancer AB 96-13-9 1-Oct-94
Dichloroacetic acid cancer AB 79-43-6 1-May-96
Dichloroacetic acid developmental, male AB 79-43-6 7-Aug-09
p-Dichlorobenzene cancer SQE 106-46-7 1-Jan-89 20
3,3'-Dichlorobenzidine cancer SQE 91-94-1 1-Oct-87 0.6
3,3'-Dichlorobenzidine dihydrochloride cancer AB 612-83-9 15-May-98
1,1-Dichloro-2,2-bis(p-chloropheny)ethylene (DDE) developmental, male AB 72-55-9 30-Mar-10
1,4-Dichloro-2-butene cancer AB 764-41-0 1-Jan-90
3,3'-Dichloro-4,4'-diamino-diphenyl ether cancer SQE 28434-86-8 1-Jan-88
1,1-Dichloroethane cancer AB 75-34-3 1-Jan-90 100
Dichloromethane (Methylene chloride) cancer SQE 75-09-2 1-Apr-88 50 200 (inhalation)
Dichlorophene developmental AB 97-23-4 27-Apr-99
Dichlorphenamide developmental FR 120-97-8 27-Feb-01
1,2-Dichloropropane cancer AB 78-87-5 1-Jan-90 9.7
1,3-Dichloro-2-propanol (1,3-DCP) cancer SQE 96-23-1 8-Oct-10
1,3-Dichloropropene cancer SQE 542-75-6 1-Jan-89
Diclofop-methyl cancer AB 51338-27-3 6-Apr-10
Diclofop methyl developmental AB 51338-27-3 5-Mar-99
Dicumarol developmental FR 66-76-2 1-Oct-92
Dieldrin cancer SQE 60-57-1 1-Jul-88 0.04
Dienestrol Delisted January 4, 2013 [Click here for the basis for delisting] cancer LC 84-17-3 1-Jan-90
Diepoxybutane cancer SQE 1464-53-5 1-Jan-88
Diesel engine exhaust cancer AB --- 1-Oct-90
Diethanolamine cancer LC 111-42-2 22-Jun-12
Di(2-ethylhexyl)phthalate cancer SQE 117-81-7 1-Jan-88 310
Di(2-ethylhexyl)phthalate developmental, male AB 117-81-7 24-Oct-03
Adultb 4200 (intravenous)
Infant boys, age 29 days to 24 monthsb 600 (intravenous)
Neonatal infant boys, age 0 to 28 daysb 210 (intravenous)
Adultb 410 (oral)
Infant boys, age 29 days to 24 monthsb 58 (oral)
Neonatal infant boys, age 0 to 28 daysb 20 (oral)
1,2-Diethylhydrazine cancer SQE 1615-80-1 1-Jan-88
Diethylstilbestrol (DES) cancer LC 56-53-1 27-Feb-87 0.002
Diethylstilbestrol (DES) developmental FR 56-53-1 1-Jul-87
Diethyl sulfate cancer SQE 64-67-5 1-Jan-88
Diflunisal developmental, female FR 22494-42-4 29-Jan-99
Diglycidyl ether Delisted April 4, 2014 [Click here for the basis for delisting] male LC 2238-07-5 7-Aug-09
Diglycidyl resorcinol ether (DGRE) cancer SQE 101-90-6 1-Jul-89 0.4
Dihydroergotamine mesylate developmental FR 6190-39-2 1-May-97
Dihydrosafrole cancer SQE 94-58-6 1-Jan-88 20
Diisononyl phthalate (DINP) cancer SQE --- 20-Dec-13
Diisopropyl sulfate cancer AB 2973-10-6 1-Apr-93
Di-isodecyl phthalate (DIDP) developmental AB 68515-49-1/ 26761-40-0 20-Apr-07 2200
Diltiazem hydrochloride developmental FR 33286-22-5 27-Feb-01
3,3'-Dimethoxybenzidine (o-Dianisidine) cancer SQE 119-90-4 1-Jan-88 0.15
3,3'-Dimethoxybenzidine dihydrochloride cancer AB 20325-40-0 1-Oct-90 0.19
3,3'-Dimethoxybenzidine-based dyes metabolized to 3,3'-dimethoxybenzidine cancer AB --- 11-Jun-04
N,N-Dimethylacetamide [Click here for the basis for addition of male reproductive endpoint, effective December 20, 2013] developmental, male SQE 127-19-5 21-May-10
4-Dimethylaminoazobenzene cancer SQE 60-11-7 1-Jan-88 0.2
trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)vinyl]-1,3,4-oxadiazole cancer SQE 55738-54-0 1-Jan-88 2
7,12-Dimethylbenz(a)anthracene cancer AB 57-97-6 1-Jan-90 0.003
3,3'-Dimethylbenzidine (ortho-Tolidine) cancer SQE 119-93-7 1-Jan-88 0.044
3,3'-Dimethylbenzidine dihydrochloride cancer AB 612-82-8 1-Apr-92 0.059
3,3'-Dimethylbenzidine-based dyes metabolized to 3,3'-dimethylbenzidine cancer AB --- 11-Jun-04
Dimethylcarbamoyl chloride cancer SQE 79-44-7 1-Jan-88 0.05
1,1-Dimethylhydrazine (UDMH) cancer LC 57-14-7 1-Oct-89
1,2-Dimethylhydrazine cancer SQE 540-73-8 1-Jan-88 0.001
2,6-Dimethyl-N-nitrosomorpholine (DMNM) cancer SQE 1456-28-6 8-Feb-13
Dimethyl sulfate cancer SQE 77-78-1 1-Jan-88
N,N-Dimethyl-p-toluidine cancer AB 99-97-8 2-May-14
Dimethylvinylchloride cancer SQE 513-37-1 1-Jul-89 20
Di-n-butyl phthalate (DBP) developmental, female, male AB 84-74-2 2-Dec-05 8.7
Di-n-hexyl phthalate (DnHP) female, male AB 84-75-3 2-Dec-05 2200 (oral)
m-Dinitrobenzene male AB 99-65-0 1-Jul-90 38
o-Dinitrobenzene male AB 528-29-0 1-Jul-90
p-Dinitrobenzene male AB 100-25-4 1-Jul-90
3,7-Dinitrofluoranthene cancer AB 105735-71-5 26-Aug-97
3,9-Dinitrofluoranthene cancer AB 22506-53-2 26-Aug-97
1,3-Dinitropyrene cancer LC 75321-20-9 2-Nov-12
1,6-Dinitropyrene cancer AB 42397-64-8 1-Oct-90
1,8-Dinitropyrene cancer AB 42397-65-9 1-Oct-90
2,4-Dinitrotoluene cancer SQE 121-14-2 1-Jul-88 2
2,4-Dinitrotoluene male AB 121-14-2 20-Aug-99
2,6-Dinitrotoluene cancer SQE 606-20-2 1-Jul-95
2,6-Dinitrotoluene male AB 606-20-2 20-Aug-99
Dinitrotoluene (technical grade) female, male AB --- 20-Aug-99
Dinitrotoluene mixture, 2,4-/2,6- cancer AB --- 1-May-96
Dinocap developmental FR 39300-45-3 1-Apr-90
Dinoseb developmental, male FR 88-85-7 1-Jan-89
Di-n-propyl isocinchomeronate (MGK Repellent 326) cancer AB 136-45-8 1-May-96
1,4-Dioxane cancer SQE 123-91-1 1-Jan-88 30
Diphenylhydantoin (Phenytoin) cancer SQE 57-41-0 1-Jan-88
Diphenylhydantoin (Phenytoin) developmental SQE 57-41-0 1-Jul-87
Diphenylhydantoin (Phenytoin), sodium salt cancer SQE 630-93-3 1-Jan-88
Direct Black 38 (technical grade) cancer SQE 1937-37-7 1-Jan-88 0.09
Direct Blue 6 (technical grade) cancer SQE 2602-46-2 1-Jan-88 0.09
Direct Brown 95 (technical grade) cancer SQE 16071-86-6 1-Oct-88 0.1
Disodium cyanodithioimidocarbonate developmental AB 138-93-2 30-Mar-99 56 (oral) 170 (oral) as 32% pesticidal formulation
Disperse Blue 1 cancer AB 2475-45-8 1-Oct-90 200
Diuron cancer AB 330-54-1 31-May-02
Doxorubicin hydrochloride (Adriamycin) cancer SQE 25316-40-9 1-Jul-87
Doxorubicin hydrochloride (Adriamycin) developmental, male FR 25316-40-9 29-Jan-99
Doxycycline (internal use) developmental FR 564-25-0 1-Jul-90
Doxycycline calcium (internal use) developmental FR 94088-85-4 1-Jan-92
Doxycycline hyclate (internal use) developmental FR 24390-14-5 1-Oct-91
Doxycycline monohydrate (internal use) developmental FR 17086-28-1 1-Oct-91
Emissions from combustion of coal cancer AB --- 7-Aug-13
Emissions from high-temperature unrefined rapeseed oil cancer AB --- 3-Jan-14
Endrin developmental AB 72-20-8 15-May-98
Environmental tobacco smoke (ETS) developmental SQE --- 9-Jun-06
Epichlorohydrin cancer SQE 106-89-8 1-Oct-87 9
Epichlorohydrin male AB 106-89-8 1-Sep-96
Epoxiconazole cancer AB 135319-73-2 15-Apr-11
Ergotamine tartrate developmental FR 379-79-3 1-Apr-90
Erionite cancer SQE 12510-42-8; 66733-21-9 1-Oct-88
Estradiol 17B cancer SQE 50-28-2 1-Jan-88 0.02
Estragole cancer SQE 140-67-0 29-Oct-99
Estrogens, steroidal cancer LC --- 19-Aug-05
Estrogen-progestogen (combined) used as menopausal therapy cancer LC --- 4-Nov-11
Estrone cancer SQE 53-16-7 1-Jan-88
Estropipate cancer, developmental FR 7280-37-7 26-Aug-97
Ethanol in alcoholic beverages cancer LC --- 29-Apr-11
Ethinylestradiol cancer SQE 57-63-6 1-Jan-88
Ethionamide developmental FR 536-33-4 26-Aug-97
Ethoprop cancer AB 13194-48-4 27-Feb-01
Ethyl acrylate cancer SQE 140-88-5 1-Jul-89
Ethyl alcohol in alcoholic beverages developmental SQE --- 1-Oct-87
Ethylbenzene cancer AB 100-41-4 11-Jun-04 54 (inhalation) 41 (oral)
Ethyl-tert-butyl ether Delisted December 13, 2013 [Clik here for the basis for delisting] male LC 637-92-3 18-Dec-09
Ethyl dipropylthiocarbamate developmental AB 759-94-4 27-Apr-99 700 (oral and inhalation) 6700 (dermal)
Ethyl-4,4'-dichlorobenzilate cancer AB 510-15-6 1-Jan-90 7
Ethylene dibromide cancer FR 106-93-4 1-Jul-87 0.2 (oral) 3 (inhalation)
Ethylene dibromide developmental, male AB 106-93-4 15-May-98
Ethylene dichloride (1,2-Dichloroethane) cancer SQE 107-06-2 1-Oct-87 10
Ethylene glycol monoethyl ether developmental, male SQE 110-80-5 1-Jan-89 750 (oral) 960 (inhalation)
Ethylene glycol monoethyl ether acetate developmental, male AB 111-15-9 1-Jan-93 1100 (oral) 1400 (inhalation)
Ethylene glycol monomethyl ether developmental, male SQE 109-86-4 1-Jan-89 63 (oral)
Ethylene glycol monomethyl ether acetate developmental, male AB 110-49-6 1-Jan-93 98 (oral)
Ethyleneimine cancer SQE 151-56-4 1-Jan-88 0.01
Ethylene oxide cancer FR 75-21-8 1-Jul-87 2
Ethylene oxide [Basis for listing changed effective November 22, 2013] female FR 75-21-8 27-Feb-87 20
Ethylene oxide [Basis for listing changed effective November 22, 2013] developmental, male FR 75-21-8 7-Aug-09
Ethylene thiourea cancer AB 96-45-7 1-Jan-88 20
Ethylene thiourea developmental SQE 96-45-7 1-Jan-93
2-Ethylhexanoic acid Delisted December 13, 2013 [Click here for the basis for delisting] developmental LC 149-57-5 7-Aug-09
Ethyl methanesulfonate cancer SQE 62-50-0 1-Jan-88
Etodolac developmental, female FR 41340-25-4 20-Aug-99
Etoposide cancer LC 33419-42-0 4-Nov-11
Etoposide developmental FR 33419-42-0 1-Jul-90
Etoposide in combination with cisplatin and bleomycin cancer LC --- 4-Nov-11
Etretinate developmental SQE 54350-48-0 1-Jul-87
Fenoxaprop ethyl developmental AB 66441-23-4 26-Mar-99
Fenoxycarb cancer AB 72490-01-8 2-Jun-00
Filgrastim developmental FR 121181-53-1 27-Feb-01
Fluazifop butyl developmental AB 69806-50-4 6-Nov-98
Flunisolide developmental, female FR 3385-03-3 15-May-98
Fluorouracil developmental SQE 51-21-8 1-Jan-89
Fluoxymesterone developmental FR 76-43-7 1-Apr-90
Flurazepam hydrochloride developmental FR 1172-18-5 1-Oct-92
Flurbiprofen developmental, female FR 5104-49-4 20-Aug-99
Flutamide developmental FR 13311-84-7 1-Jul-90
Fluticasone propionate developmental FR 80474-14-2 15-May-98
Fluvalinate developmental AB 69409-94-5 6-Nov-98
Folpet cancer SQE 133-07-3 1-Jan-89 200
Formaldehyde (gas) cancer SQE 50-00-0 1-Jan-88 40
2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole cancer SQE 3570-75-0 1-Jan-88 0.3
Fumonisin B1 cancer AB 116355-83-0 14-Nov-03
Furan cancer AB 110-00-9 1-Oct-93
Furazolidone cancer AB 67-45-8 1-Jan-90
Furmecyclox cancer AB 60568-05-0 1-Jan-90 20
Fusarin C cancer SQE 79748-81-5 1-Jul-95
Gallium arsenide cancer LC 1303-00-0 1-Aug-08
Ganciclovir cancer, developmental, male FR 82410-32-0 26-Aug-97
Ganciclovir sodium developmental, male FR 107910-75-8 26-Aug-97
Gasoline engine exhaust (condensates/extracts) cancer AB --- 1-Oct-90
Gemfibrozil cancer FR 25812-30-0 22-Dec-00
Gemfibrozil female, male FR 25812-30-0 20-Aug-99
Glass wool fibers (inhalable and biopersistent) cancer AB --- 1-Jul-90
Glu-P-1 (2-Amino-6-methyldipyrido[1,2- a:3',2'-d]imidazole) cancer AB 67730-11-4 1-Jan-90 0.1
Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole) cancer AB 67730-10-3 1-Jan-90 0.5
Glycidaldehyde cancer SQE 765-34-4 1-Jan-88
Glycidol cancer AB 556-52-5 1-Jul-90 0.54
Goserelin acetate developmental, female, male FR 65807-02-5 26-Aug-97
Griseofulvin cancer AB 126-07-8 1-Jan-90
Gyromitrin (Acetaldehyde methylformylhydrazone) cancer SQE 16568-02-8 1-Jan-88 0.07
Halazepam developmental FR 23092-17-3 1-Jul-90
Halobetasol propionate developmental FR 66852-54-8 20-Aug-99
Haloperidol developmental, female FR 52-86-8 29-Jan-99
Halothane developmental FR 151-67-7 1-Sep-96
HC Blue 1 cancer SQE 2784-94-3 1-Jul-89 10
Heptachlor cancer SQE 76-44-8 1-Jul-88 0.2
Heptachlor developmental AB 76-44-8 20-Aug-99
Heptachlor epoxide cancer SQE 1024-57-3 1-Jul-88 0.08
Herbal remedies containing plant species of the genus Aristolochia cancer LC --- 9-Jul-04
Hexachlorobenzene cancer SQE 118-74-1 1-Oct-87 0.4
Hexachlorobenzene developmental SQE 118-74-1 1-Jan-89
Hexachlorobutadiene cancer AB 87-68-3 3-May-11
Hexachlorocyclohexane (technical grade) cancer SQE --- 1-Oct-87 0.2
Hexachlorocyclohexane (alpha isomer) 0.3
Hexachlorocyclohexane (beta isomer) 0.5
Hexachlorocyclohexane (gamma isomer) 0.6
Hexachlorodibenzodioxin cancer SQE 34465-46- 8 1-Apr-88 0.0002
Hexachloroethane cancer AB 67-72-1 1-Jul-90 20
2,4-Hexadienal (89% trans, trans isomer; 11% cis, trans isomer) cancer AB --- 4-Mar-05
Hexafluoroacetone [Basis for listing changed effective June 6, 2014] developmental, male LC SQE 684-16-2 1-Aug-08
Hexamethylphosphoramide cancer SQE 680-31-9 1-Jan-88
Hexamethylphosphoramide male AB 680-31-9 1-Oct-94
Histrelin acetate developmental FR --- 15-May-98
Hydramethylnon developmental, male AB 67485-29-4 5-Mar-99 120 (oral)
Hydrazine cancer SQE 302-01-2 1-Jan-88 0.04
Hydrazine sulfate cancer SQE 10034-93-2 1-Jan-88 0.2
Hydrazobenzene (1,2-Diphenylhydrazine) cancer SQE 122-66-7 1-Jan-88 0.8
Hydrogen cyanide (HCN) and cyanide salts (CN salts) male AB --- 5-Jul-13
Cyanide salts that readily dissociate in solution (expressed as cyanide)f 9.8
Hydrogen cyanidef 10 (oral)
Sodium cyanidef 19 (oral)
Potassium cyanidef 25 (oral)
1-Hydroxyanthraquinone cancer LC 129-43-1 27-May-05
Hydroxyurea developmental FR 127-07-1 1-May-97
Idarubicin hydrochloride developmental, male FR 57852-57-0 20-Aug-99
Ifosfamide developmental FR 3778-73-2 1-Jul-90
Iodine-131 developmental SQE 10043-66-0 1-Jan-89
Imazalil cancer AB 35554-44-0 20-May-11 11
Indeno [1,2,3-cd]pyrene cancer SQE 193-39-5 1-Jan-88
Indium phosphide cancer AB 22398-80-7 27-Feb-01
IQ (2-Amino-3-methylimidazo[4,5-f] quinoline) cancer AB 76180-96-6 1-Apr-90 0.5
Iprodione cancer AB 36734-19-7 1-May-96
Iprovalicarb cancer AB 140923-17-7/ 140923-25-7 1-Jun-07
Iron dextran complex cancer SQE 9004-66-4 1-Jan-88
Isobutyl nitrite cancer AB 542-56-3 1-May-96 7.4
Isoprene cancer AB 78-79-5 1-May-96
Isopyrazam cancer AB 881685-58-1 24-Jul-12
Isosafrole Delisted December 8, 2006 [Click here for the basis for delisting] cancer LC 120-58-1 1-Oct-89
Isotretinoin developmental SQE 4759-48-2 1-Jul-87
Isoxaflutole cancer AB 141112-29-0 22-Dec-00
Kresoxim-methyl cancer AB 143390-89-0 3-Feb-12
Lactofen cancer SQE 77501-63-4 1-Jan-89
Lasiocarpine cancer SQE 303-34-4 1-Apr-88 0.09
Lead [Basis for listing changed effective November 22, 2013] developmental, female, male FR --- 27-Feb-87 0.5
Lead and lead compounds cancer AB --- 1-Oct-92
Lead 15 (oral)
Lead acetate cancer SQE 301-04-2 1-Jan-88 23 (oral)
Lead phosphate cancer SQE 7446-27-7 1-Apr-88 58 (oral)
Lead subacetate cancer LC 1335-32-6 1-Oct-89 41 (oral)
Leather dust cancer LC --- 29-Apr-11
Leuprolide acetate developmental, female, male FR 74381-53-6 26-Aug-97
Levodopa developmental FR 59-92-7 29-Jan-99
Levonorgestrel implants female FR 797-63-7 15-May-98
Lindane and other hexachlorocyclohexane isomers cancer LC --- 1-Oct-89
Linuron developmental AB 330-55-2 19-Mar-99 460
Lithium carbonate developmental FR 554-13-2 1-Jan-91
Lithium citrate developmental FR 919-16-4 1-Jan-91
Lorazepam developmental FR 846-49-1 1-Jul-90
Lovastatin developmental FR 75330-75-5 1-Oct-92
Lynestrenol cancer AB 52-76-6 27-Feb-01
Malonaldehyde, sodium salt cancer AB 24382-04-5 29-Apr-11
Mancozeb cancer AB 8018-01-7 1-Jan-90
Maneb cancer AB 12427-38-2 1-Jan-90
Marijuana smoke cancer SQE --- 19-Jun-09
Me-A-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) cancer AB 68006-83-7 1-Jan-90 0.6
Mebendazole developmental FR 31431-39-7 20-Aug-99
Medroxyprogesterone acetate cancer AB 71-58-9 1-Jan-90
Medroxyprogesterone acetate developmental FR 71-58-9 1-Apr-90
Megestrol acetate cancer FR 595-33-5 28-Mar-14
Megestrol acetate developmental FR 595-33-5 1-Jan-91
MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) cancer AB 77094-11-2 1-Oct-94 0.46
MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) cancer AB 77500-04-0 1-Oct-94 0.41
Melphalan cancer LC 148-82-3 27-Feb-87 0.005
Melphalan developmental FR 148-82-3 1-Jul-90
Menotropins developmental FR 9002-68-0 1-Apr-90
Mepanipyrim cancer AB 110235-47-7 1-Jul-08
Meprobamate developmental FR 57-53-4 1-Jan-92
Mercaptopurine developmental FR 6112-76-1 1-Jul-90
Mercury and mercury compounds developmental AB --- 1-Jul-90
Merphalan cancer SQE 531-76-0 1-Apr-88
Mestranol cancer SQE 72-33-3 1-Apr-88
Metam potassium cancer AB 137-41-7 31-Dec-10
Methacycline hydrochloride developmental FR 3963-95-9 1-Jan-91
Metham sodium cancer AB 137-42-8 6-Nov-98
Metham sodium developmental AB 137-42-8 15-May-98
Methanol developmental AB 67-56-1 16-Mar-12 47,000 (inhalation) 23,000 (oral)
Methazole developmental AB 20354-26-1 1-Dec-99
Methimazole developmental FR 60-56-0 1-Jul-90
Methotrexate developmental SQE 59-05-2 1-Jan-89
Methotrexate sodium developmental FR 15475-56-6 1-Apr-90
5-Methoxypsoralen with ultraviolet A therapy cancer SQE 484-20-8 1-Oct-88
8-Methoxypsoralen with ultraviolet A therapy cancer LC 298-81-7 27-Feb-87
2-Methylaziridine (Propyleneimine) cancer SQE 75-55-8 1-Jan-88 0.028
Methylazoxymethanol cancer SQE 590-96-5 1-Apr-88
Methylazoxymethanol acetate cancer SQE 592-62-1 1-Apr-88
Methyl bromide, as a structural fumigant developmental FR 74-83-9 1-Jan-93 810 (inhalation)
Methyl n-butyl ketone male LC 591-78-6 7-Aug-09
Methyl carbamate cancer AB 598-55-0 15-May-98 160
Methyl chloride developmental AB 74-87-3 10-Mar-00
Methyl chloride [Basis for listing changed effective March 7, 2014] male AB 74-87-3 7-Aug-09
3-Methylcholanthrene cancer AB 56-49-5 1-Jan-90 0.03
5-Methylchrysene cancer SQE 3697-24-3 1-Apr-88 0.0084 (oral)
4,4'-Methylene bis(2-chloroaniline) cancer FR 101-14-4 1-Jul-87 0.5
4,4'-Methylene bis(N,N-dimethyl)benzenamine cancer LC 101-61-1 1-Oct-89 20
4,4'-Methylene bis(2-methylaniline) cancer SQE 838-88-0 1-Apr-88 0.8
4,4'-Methylenedianiline cancer SQE 101-77-9 1-Jan-88 0.4
4,4'-Methylenedianiline dihydrochloride cancer SQE 13552-44-8 1-Jan-88 0.6
Methyleugenol cancer AB 93-15-2 16-Nov-01
Methylhydrazine and its salts cancer AB --- 1-Jul-92
Methylhydrazine 0.058 (oral) 0.090 (inhalation)
Methylhydrazine sulfate 0.18
2-Methylimidazole cancer LC 693-98-1 22-Jun-12
4-Methylimidazole cancer AB 822-36-6 7-Jan-11 29
Methyl iodide cancer SQE 74-88-4 1-Apr-88
Methyl isobutyl ketone cancer LC 108-10-1 4-Nov-11
Methyl isobutyl ketone (MIBK) developmental AB 108-10-1 28-Mar-14
Methyl isocyanate (MIC) developmental, female SQE 624-83-9 12-Nov-10
Methyl isopropyl ketone Delisted April 4, 2014 [Click for the basis for delisting] developmental LC 563-80-4 17-Feb-12
Methyl mercury developmental SQE --- 1-Jul-87
Methylmercury compounds cancer AB --- 1-May-96
Methyl methanesulfonate cancer SQE 66-27-3 1-Apr-88 7
2-Methyl-1-nitroanthraquinone (of uncertain purity) cancer SQE 129-15-7 1-Apr-88 0.2
N-Methyl-N'-nitro-N-nitrosoguanidine cancer SQE 70-25-7 1-Apr-88 0.08
N-Methylolacrylamide cancer AB 924-42-5 1-Jul-90
N-Methylpyrrolidone developmental AB 872-50-4 15-Jun-01 3200 (inhalation) 17000 (dermal)
α-Methyl styrene (alpha-Methylstyrene) cancer LC 98-83-9 2-Nov-12
α-Methyl styrene Delisted April 4, 2014 [Click for the basis for delisting] female LC 98-83-9 29-Jul-11
Methyltestosterone developmental FR 58-18-4 1-Apr-90
Methylthiouracil cancer LC 56-04-2 1-Oct-89 2
Metiram cancer AB 9006-42-2 1-Jan-90
Metiram developmental AB 9006-42-2 30-Mar-99
Metronidazole cancer SQE 443-48-1 1-Jan-88
Michler's ketone cancer SQE 90-94-8 1-Jan-88 0.8
Midazolam hydrochloride developmental FR 59467-96-8 1-Jul-90
Minocycline hydrochloride (internal use) developmental FR 13614-98-7 1-Jan-92
Mirex cancer SQE 2385-85-5 1-Jan-88 0.04
Misoprostol developmental FR 59122-46-2 1-Apr-90
Mitomycin C cancer SQE 50-07-7 1-Apr-88 0.00009
Mitoxantrone hydrochloride developmental FR 70476-82-3 1-Jul-90
Molinate developmental, female, male AB 2212-67-1 11-Dec-09
MON 4660 (dichloroacetyl-1-oxa-4-azaspiro(4,5)-decane cancer AB 71526-07-3 22-Mar-11
MON 13900 (furilazole) cancer AB 121776-33-8 22-Mar-11
3-Monochloropropane-1,2-diol (3-MCDP) cancer SQE 96-24-2 8-Oct-10
Monocrotaline cancer SQE 315-22-0 1-Apr-88 0.07
MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) cancer LC 113803-47-7 4-Nov-11
5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)-amino]-2-oxazolidinone cancer SQE 139-91-3 1-Apr-88 0.18
Mustard Gas cancer LC 505-60-2 27-Feb-87
MX (3-chloro-4-dichloromethyl-5-hydroxy-2(5H)-furanone) cancer SQE 77439-76-0 22-Dec-00 0.11
Myclobutanil developmental, male AB 88671-89-0 16-Apr-99
Nabam developmental AB 142-59-6 30-Mar-99
Nafarelin acetate developmental FR 86220-42-0 1-Apr-90
Nafenopin cancer SQE 3771-19-5 1-Apr-88
Nalidixic acid cancer AB 389-08-2 15-May-98 28
Naphthalene cancer AB 91-20-3 19-Apr-02 5.8
1-Naphthylamine cancer LC 134-32-7 1-Oct-89
2-Naphthylamine cancer LC 91-59-8 27-Feb-87 0.4
Neomycin sulfate (internal use) developmental FR 1405-10-3 1-Oct-92
Netilmicin sulfate developmental FR 56391-57-2 1-Jul-90
Nickel (Metallic) cancer LC 7440-02-0 1-Oct-89
Nickel acetate cancer LC 373-02-4 1-Oct-89
Nickel carbonate cancer LC 3333-67-3 1-Oct-89
Nickel carbonyl cancer SQE 13463-39-3 1-Oct-87
Nickel carbonyl developmental AB 13463-39-3 1-Sep-96
Nickel compounds cancer LC --- 7-May-04
Nickel hydroxide cancer LC 12054-48-7; 12125-56-3 1-Oct-89
Nickelocene cancer LC 1271-28-9 1-Oct-89
Nickel oxide cancer LC 1313-99-1 1-Oct-89
Nickel refinery dust from the pyrometallurgical process cancer SQE --- 1-Oct-87 0.8
Nickel subsulfide cancer SQE 12035-72-2 1-Oct-87 0.4
Nicotine developmental FR 54-11-5 1-Apr-90
Nifedipine developmental, female, male FR 21829-25-4 29-Jan-99
Nimodipine developmental FR 66085-59-4 24-Apr-01
Niridazole cancer SQE 61-57-4 1-Apr-88
Nitrapyrin cancer AB 1929-82-4 5-Oct-05
Nitrapyrin developmental AB 1929-82-4 30-Mar-99
Nitrilotriacetic acid cancer SQE 139-13-9 1-Jan-88 100
Nitrilotriacetic acid, trisodium salt monohydrate cancer SQE 18662-53-8 1-Apr-89 70
5-Nitroacenaphthene cancer SQE 602-87-9 1-Apr-88 6
5-Nitro-o-anisidine Delisted December 8, 2006 [Click here for the basis for delisting] cancer LC 99-59-2 1-Oct-89 10
o-Nitroanisole cancer AB 91-23-6 1-Oct-92
Nitrobenzene cancer AB 98-95-3 26-Aug-97
Nitrobenzene male AB 98-95-3 30-Mar-10
4-Nitrobiphenyl cancer SQE 92-93-3 1-Apr-88
6-Nitrochrysene cancer AB 7496-02-8 1-Oct-90
Nitrofen (technical grade) cancer SQE 1836-75-5 1-Jan-88 9
2-Nitrofluorene cancer AB 607-57-8 1-Oct-90
Nitrofurantoin male AB 67-20-9 1-Apr-91
Nitrofurazone cancer AB 59-87-0 1-Jan-90 0.5
1-[(5-Nitrofurfurylidene)-amino]-2-imidazolidinone cancer SQE 555-84-0 1-Apr-88 0.4
N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide cancer SQE 531-82-8 1-Apr-88 0.5
Nitrogen mustard (Mechlorethamine) cancer SQE 51-75-2 1-Jan-88
Nitrogen mustard (Mechlorethamine) developmental SQE 51-75-2 1-Jan-89
Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) cancer SQE 55-86-7 1-Apr-88
Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) developmental FR 55-86-7 1-Jul-90
Nitrogen mustard N-oxide cancer SQE 126-85-2 1-Apr-88
Nitrogen mustard N-oxide hydrochloride cancer SQE 302-70-5 1-Apr-88
Nitromethane cancer AB 75-52-5 1-May-97 39
2-Nitropropane cancer SQE 79-46-9 1-Jan-88
1-Nitropyrene cancer AB 5522-43-0 1-Oct-90
4-Nitropyrene cancer AB 57835-92-4 1-Oct-90
N-Nitrosodiethanolamine cancer SQE 1116-54-7 1-Jan-88 0.3
N-Nitrosodiethylamine cancer SQE 55-18-5 1-Oct-87 0.02
N-Nitrosodimethylamine cancer SQE 62-75-9 1-Oct-87 0.04
N-Nitrosodi-n-butylamine cancer SQE 924-16-3 1-Oct-87 0.06
N-Nitrosodi-n-propylamine cancer SQE 621-64-7 1-Jan-88 0.1
p-Nitrosodiphenylamine cancer SQE 156-10-5 1-Jan-88 30
N-Nitrosodiphenylamine cancer SQE 86-30-6 1-Apr-88 80
3-(N-Nitrosomethylamino) propionitrile cancer AB 60153-49-3 1-Apr-90
4-(N-Nitrosomethylamino)-1-(3-pyridyl)1-butanone cancer AB 64091-91-4 1-Apr-90 0.014
N-Nitrosomethylethylamine cancer LC 10595-95-6 1-Oct-89 0.03
N-Nitrosomethylvinylamine cancer SQE 4549-40-0 1-Jan-88
N-Nitrosomorpholine cancer SQE 59-89-2 1-Jan-88 0.1
N-Nitroso-N-ethylurea cancer SQE 759-73-9 1-Oct-87 0.03
N-Nitroso-N-methylurea cancer SQE 684-93-5 1-Oct-87 0.006
N-Nitroso-N-methylurethane cancer SQE 615-53-2 1-Apr-88 0.006
N-Nitrosonornicotine cancer SQE 16543-55-8 1-Jan-88 0.5
N-Nitrosopiperidine cancer SQE 100-75-4 1-Jan-88 0.07
N-Nitrosopyrrolidine cancer SQE 930-55-2 1-Oct-87 0.3
N-Nitrososarcosine cancer SQE 13256-22-9 1-Jan-88
o-Nitrotoluene cancer AB 88-72-2 15-May-98
Nitrous oxide [Basis for listing changed effective November 8, 2013] developmental, female AB 10024-97-2 1-Aug-08
Norethisterone (Norethindrone) cancer LC 68-22-4 1-Oct-89
Norethisterone (Norethindrone) developmental FR 68-22-4 1-Apr-90
Norethisterone acetate (Norethindrone acetate) developmental FR 51-98-9 1-Oct-91
Norethisterone (Norethindrone) /Ethinyl estradiol developmental FR 68-22-4/ 57-63-6 1-Apr-90
Norethisterone (Norethindrone) /Mestranol developmental FR 68-22-4/ 72-33-3 1-Apr-90
Norethynodrel cancer AB 68-23-5 27-Feb-01
Norgestrel developmental FR 6533-00-2 1-Apr-90
Ochratoxin A cancer AB 303-47-9 1-Jul-90
Oil Orange SS cancer SQE 2646-17-5 1-Apr-88
Oral contraceptives, combined cancer LC --- 1-Oct-89
Oral contraceptives, sequential cancer LC --- 1-Oct-89
Oryzalin cancer AB 19044-88-3 12-Sep-08
Oxadiazon cancer SQE 19666-30-9 1-Jul-91
Oxadiazon developmental AB 19666-30-9 15-May-98
Oxazepam cancer AB 604-75-1 1-Oct-94
Oxazepam developmental FR 604-75-1 1-Oct-92
p,p'-Oxybis(benzenesulfonyl hydrazide) Delisted December 13, 2013 [Click here for the basis for delisting] developmental LC 80-51-3 7-Aug-09
Oxydemeton methyl female, male AB 301-12-2 6-Nov-98
Oxymetholone cancer SQE 434-07-1 1-Jan-88
Oxymetholone developmental FR 434-07-1 1-May-97
Oxytetracycline (internal use) developmental FR 79-57-2 1-Jan-91
Oxytetracycline hydrochloride (internal use) developmental FR 2058-46-0 1-Oct-91
Oxythioquinox (Chinomethionat) cancer AB 2439-01-2 20-Aug-99
Oxythioquinox (Chinomethionat) developmental AB 2439-01-2 6-Nov-98
Paclitaxel developmental, female, male FR 33069-62-4 26-Aug-97
Palygorskite fibers (> 5mm in length) cancer AB 12174-11-7 28-Dec-99
Panfuran S cancer SQE 794-93-4 1-Jan-88
Paramethadione developmental FR 115-67-3 1-Jul-90
Penicillamine developmental FR 52-67-5 1-Jan-91
Pentachlorophenol cancer AB 87-86-5 1-Jan-90 40
Pentobarbital sodium developmental FR 57-33-0 1-Jul-90
Pentosan polysulfate sodium cancer LC --- 18-Apr-14
Pentostatin developmental FR 53910-25-1 1-Sep-96
Phenacemide developmental FR 63-98-9 1-Jul-90
Phenacetin cancer LC 62-44-2 1-Oct-89 300
Phenazopyridine cancer SQE 94-78-0 1-Jan-88 4
Phenazopyridine hydrochloride cancer SQE 136-40-3 1-Jan-88 5
Phenesterin cancer SQE 3546-10-9 1-Jul-89 0.005
Phenobarbital cancer AB 50-06-6 1-Jan-90 2
Phenolphthalein cancer AB 77-09-8 15-May-98
Phenoxybenzamine cancer SQE 59-96-1 1-Apr-88 0.2
Phenoxybenzamine hydrochloride cancer SQE 63-92-3 1-Apr-88 0.3
Phenprocoumon developmental FR 435-97-2 1-Oct-92
o-Phenylenediamine and its salts cancer AB 95-54-5 15-May-98
o-Phenylenediamine 26
o-Phenylenediamine dihydochloride 44
Phenyl glycidyl ether cancer AB 122-60-1 1-Oct-90 5
Phenyl glycidyl ether male LC 122-60-1 7-Aug-09
Delisted April 4, 2014 [Click here
for the basis for delisting]
Phenylhydrazine and its salts cancer AB --- 1-Jul-92
Phenylhydrazine 1
Phenylhydrazine hydrochloride 1.4
o-Phenylphenate, sodium cancer AB 132-27-4 1-Jan-90 200
o-Phenylphenol cancer AB 90-43-7 4-Aug-00
Phenylphosphine [Basis for listing changed effective June 6, 2014] developmental male LC SQE 638-21-1 7-Aug-09
PhiP(2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine) cancer AB 105650-23-5 1-Oct-94
Pimozide developmental, female FR 2062-78-4 20-Aug-99
Pioglitazone cancer LC 111025-46-8 18-Apr-14
Pipobroman developmental FR 54-91-1 1-Jul-90
Pirimicarb cancer AB 23103-98-2 1-Jul-08
Plicamycin developmental FR 18378-89-7 1-Apr-90
Polybrominated biphenyls cancer SQE --- 1-Jan-88 0.02
Polybrominated biphenyls developmental AB --- 1-Oct-94
Polychlorinated biphenyls cancer LC --- 1-Oct-89 0.09
Polychlorinated biphenyls developmental SQE --- 1-Jan-91
Polychlorinated biphenyls (containing 60 or more percent percent chlorine by molecular weight) cancer SQE --- 1-Jan-88
Polychlorinated dibenzo-p-dioxins cancer FR --- 1-Oct-92
Polychlorinated dibenzofurans cancer FR --- 1-Oct-92
Polygeenan cancer SQE 53973-98-1 1-Jan-88 1200
Ponceau MX cancer SQE 3761-53-3 1-Apr-88 200
Ponceau 3R cancer SQE 3564-09-8 1-Apr-88 40
Potassium bromate cancer AB 7758-01-2 1-Jan-90 1
Potassium dimethyldithiocarbamate developmental AB 128-03-0 30-Mar-99 720
Pravastatin sodium developmental FR 81131-70-6 3-Mar-00
Prednisolone sodium phosphate developmental FR 125-02-0 20-Aug-99
Primidone cancer AB 125-33-7 20-Aug-99
Procarbazine cancer SQE 671-16-9 1-Jan-88 0.05
Procarbazine hydrochloride cancer SQE 366-70-1 1-Jan-88 0.06
Procarbazine hydrochloride developmental FR 366-70-1 1-Jul-90
Procymidone cancer AB 32809-16-8 1-Oct-94
Progesterone cancer SQE 57-83-0 1-Jan-88
Pronamide cancer AB 23950-58-5 1-May-96
Propachlor cancer AB 1918-16-7 27-Feb-01
1,3-Propane sultone cancer SQE 1120-71-4 1-Jan-88 0.3
Propargite cancer AB 2312-35-8 1-Oct-94
Propargite developmental AB 2312-35-8 15-Jun-99
beta-Propiolactone cancer SQE 57-57-8 1-Jan-88 0.05
Propoxur cancer AB 114-26-1 11-Aug-06
Propylene glycol mono-t-butyl ether cancer AB 57018-52-7 11-Jun-04
Propylene oxide cancer SQE 75-56-9 1-Oct-88
Propylthiouracil cancer SQE 51-52-5 1-Jan-88 0.7
Propylthiouracil developmental FR 51-52-5 1-Jul-90
Pulegone cancer LC 89-82-7 18-Apr-14
Pymetrozine cancer AB 123312-89-0 22-Mar-11
Pyridine cancer AB 110-86-1 17-May-02
Pyrimethamine developmental FR 58-14-0 29-Jan-99
Quazepam developmental FR 36735-22-5 26-Aug-97
Quinoline and its strong acid salts cancer SQE --- 24-Oct-97
Quizalofop-ethyl male SQE 76578-14-8 24-Dec-99 590
Radionuclides cancer SQE --- 1-Jul-89
Reserpine cancer LC 50-55-5 1-Oct-89 0.06
Residual (heavy) fuel oils cancer AB --- 1-Oct-90
Resmethrin cancer AB 10453-86-8 1-Jul-08
Resmethrin developmental AB 10453-86-8 6-Nov-98
Retinol/retinyl esters, when in daily dosages in excess of 10,000 IU, or 3,000 retinol equivalents. (NOTE: Retinol/retinyl esters are required and essential for maintenance of normal reproductive function. The recommended daily level during pregnancy is 8,000 IU.) developmental SQE --- 1-Jul-89
Ribavirin developmental FR 36791-04-5 1-Apr-90
Ribavirin male FR 36791-04-5 27-Feb-01
Riddelliine cancer LC 23246-96-0 3-Dec-04
Rifampin developmental, female FR 13292-46-1 27-Feb-01
Saccharin Delisted April 6, 2001 [Click here for the basis for delisting] cancer LC 81-07-2 1-Oct-89
Saccharin, sodium Delisted January 17, 2003 [Click here for the basis for delisting] cancer SQE 128-44-9 1-Jan-88
Safrole cancer SQE 94-59-7 1-Jan-88 3
Salted fish, Chinese-style cancer LC --- 29-Apr-11
Secobarbital sodium developmental FR 309-43-3 1-Oct-92
Selenium sulfide cancer LC 7446-34-6 1-Oct-89
Sermorelin acetate developmental FR --- 20-Aug-99
Shale-oils cancer AB 68308-34-9 1-Apr-90
Silica, crystalline (airborne particles of respirable size) cancer SQE --- 1-Oct-88
Sodium dimethyldithiocarbamate developmental AB 128-04-1 30-Mar-99 23 (oral) 58 (oral) as a 40% pesticidal formulation
Sodium fluoroacetate male AB 62-74-8 6-Nov-98
Soots, tars, and mineral oils (untreated and mildly treated oils and used engine oils) cancer LC --- 27-Feb-87
Spirodiclofen cancer AB 148477-71-8 8-Oct-10
Spironolactone cancer FR 52-01-7 1-May-97
Stanozolol cancer FR 10418-03-8 1-May-97
Sterigmatocystin cancer SQE 10048-13-2 1-Apr-88 0.02
Streptomycin sulfate developmental 3810-74-0 1-Jan-91
Streptozocin (streptozotocin) developmental, female, male FR 18883-66-4 20-Aug-99
Streptozotocin (streptozocin) cancer SQE 18883-66-4 1-Jan-88 0.006
Strong inorganic acid mists containing sulfuric acid cancer AB --- 14-Mar-03
Styrene oxide cancer SQE 96-09-3 1-Oct-88 4
Sulfallate cancer SQE 95-06-7 1-Jan-88 4
Sulfasalazine (salicylazosulfapyridine) cancer AB 599-79-1 15-May-98
Sulfasalazine (salicylazosulfapyridine) male FR 599-79-1 29-Jan-99
Sulfur dioxidee developmental SQE 7446-09-5 29-Jul-11 10000
Sulindac developmental, female FR 38194-50-2 29-Jan-99
Talc containing asbestiform fibers cancer AB --- 1-Apr-90
Tamoxifen and its salts cancer SQE 10540-29-1 1-Sep-96
Tamoxifen citrate developmental FR 54965-24-1 1-Jul-90
Temazepam developmental FR 846-50-4 1-Apr-90
Teniposide developmental FR 29767-20-2 1-Sep-96
Terbacil developmental AB 5902-51-2 18-May-99
Terrazole cancer AB 2593-15-9 1-Oct-94
Testosterone and its esters cancer SQE 58-22-0 1-Apr-88
Testosterone cypionate developmental FR 58-20-8 1-Oct-91
Testosterone enanthate developmental FR 315-37-7 1-Apr-90
3,3',4,4'-Tetrachloroazobenzene cancer AB 14047-09-7 24-Jul-12
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) cancer SQE 1746-01-6 1-Jan-88 0.000005
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) developmental AB 1746-01-6 1-Apr-91
1,1,1,2-Tetrachloroethane cancer LC 630-20-6 13-Sep-13
1,1,2,2-Tetrachloroethane cancer AB 79-34-5 1-Jul-90 3
Tetrachloroethylene (Perchloroethylene) cancer SQE 127-18-4 1-Apr-88 14
p-a,a,a-Tetrachlorotoluene cancer AB 5216-25-1 1-Jan-90
Tetracycline (internal use) developmental FR 60-54-8 1-Oct-91
Tetracyclines (internal use) developmental FR --- 1-Oct-92
Tetracycline hydrochloride (internal use) developmental FR 64-75-5 1-Jan-91
Tetrafluoroethylene cancer AB 116-14-3 1-May-97
Tetranitromethane cancer AB 509-14-8 1-Jul-90 0.059
Thalidomide developmental SQE 50-35-1 1-Jul-87
Thioacetamide cancer SQE 62-55-5 1-Jan-88 0.1
4,4'-Thiodianiline cancer SQE 139-65-1 1-Apr-88 0.05
Thiodicarb cancer AB 59669-26-0 20-Aug-99
Thioguanine developmental FR 154-42-7 1-Jul-90
Thiophanate methyl female, male AB 23564-05-8 18-May-99 600 (oral)
Thiouracil cancer AB 141-90-2 11-Jun-04
Thiourea cancer SQE 62-56-6 1-Jan-88 10
Thorium dioxide cancer LC 1314-20-1 27-Feb-87
Titanium dioxide (airborne, unbound particles of respirable size) cancer LC --- 2-Sep-11
Tobacco, oral use of smokeless products cancer SQE --- 1-Apr-88
Tobacco smoke cancer SQE --- 1-Apr-88
Tobacco smoke (primary) developmental, female, male SQE --- 1-Apr-88
Tobramycin sulfate developmental FR 49842-07-1 1-Jul-90
Toluene developmental SQE 108-88-3 1-Jan-91 7000c
Toluene [Click here for the basis for the removal of female reproductive endpoint effective March 7, 2014] female LC 108-88-3 7-Aug-09
Toluene diisocyanate cancer LC 26471-62-5 1-Oct-89 20
o-Toluidine cancer SQE 95-53-4 1-Jan-88 4
o-Toluidine hydrochloride cancer SQE 636-21-5 1-Jan-88 5
para-Toluidine Delisted October 29, 1999 [Click here for the basis for delisting] cancer AB 106-49-0 1-Jan-90
Toxaphene (Polychlorinated camphenes) cancer SQE 8001-35-2 1-Jan-88 0.6
Toxins derived from Fusarium moniliforme (Fusarium verticillioides) cancer LC --- 7-Aug-09
Treosulfan cancer LC 299-75-2 27-Feb-87
Triadimefon developmental, female, male AB 43121-43-3 30-Mar-99
Triamterene cancer LC 396-01-0 18-Apr-14
Triazolam developmental FR 28911-01-5 1-Apr-90
S,S,S-Tributyl phosphorotrithioate (Tribufos, DEF) cancer AB 78-48-8 25-Feb-11
Tributyltin methacrylate developmental AB 2155-70-6 1-Dec-99
Trichlormethine (Trimustine hydrochloride) cancer AB 817-09-4 1-Jan-92
Trichloroacetic acid cancer LC 76-03-9 13-Sep-13
Trichloroethylene cancer SQE 79-01-6 1-Apr-88 14 (oral) 50 (inhalation)
Trichloroethylene developmental, male AB 79-01-6 31-Jan-14
2,4,6-Trichlorophenol cancer SQE 88-06-2 1-Jan-88 10
1,2,3-Trichloropropane cancer AB 96-18-4 1-Oct-92
Trientine hydrochloride developmental FR 38260-01-4 27-Feb-01
Triforine developmental AB 26644-46-2 18-Jun-99
1,3,5-Triglycidyl-s-triazinetrione Delisted December 13, 2013 [Click here for the basis for delisting] male LC 2451-62-9 7-Aug-09
Trilostane developmental FR 13647-35-3 1-Apr-90
Trimethadione developmental FR 127-48-0 1-Jan-91
2,4,5-Trimethylaniline and its strong acid salts cancer SQE --- 24-Oct-97
Trimethyl phosphate cancer AB 512-56-1 1-May-96 24
Trimetrexate glucuronate developmental FR 82952-64-5 26-Aug-97
2,4.6-Trinitrotoluene (TNT) cancer SQE 118-96-7 19-Dec-08 8.2
Triphenyltin hydroxide cancer AB 76-87-9 1-Jul-92
Triphenyltin hydroxide developmental AB 76-87-9 18-Mar-02
Tris(aziridinyl)-p-benzoquinone (Triaziquone) Delisted December 8, 2006 [Click here for the basis for delisting] cancer LC 68-76-8 1-Oct-89
Tris(1-aziridinyl)phosphine sulfide (Thiotepa) cancer SQE 52-24-4 1-Jan-88 0.06
Tris(2-chloroethyl) phosphate cancer AB 115-96-8 1-Apr-92
Tris(2,3-dibromopropyl)phosphate cancer SQE 126-72-7 1-Jan-88 0.3
Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) cancer SQE 13674-87-8 28-Oct-11 5.4
Trp-P-1 (Tryptophan-P-1) cancer SQE 62450-06-0 1-Apr-88 0.03
Trp-P-2 (Tryptophan-P-2) cancer SQE 62450-07-1 1-Apr-88 0.2
Trypan blue (commercial grade) cancer LC 72-57-1 1-Oct-89
Unleaded gasoline (wholly vaporized) cancer SQE --- 1-Apr-88
Uracil mustard cancer SQE 66-75-1 1-Apr-88
Uracil mustard developmental, female, male FR 66-75-1 1-Jan-92
Urethane (Ethyl carbamate) cancer SQE 51-79-6 1-Jan-88 0.7
Urethane (Ethyl carbamate) developmental AB 51-79-6 1-Oct-94
Urofollitropin developmental FR 97048-13-0 1-Apr-90
Valproate (Valproic acid) developmental SQE 99-66-1 1-Jul-87
Vanadium pentoxide (orthorhombic crystalline form) cancer AB 1314-62-1 11-Feb-05
Vinblastine sulfate developmental FR 143-67-9 1-Jul-90
Vinclozolin cancer AB 50471-44-8 20-Aug-99
Vinclozolin developmental AB 50471-44-8 15-May-98
Vincristine sulfate developmental FR 2068-78-2 1-Jul-90
Vinyl bromide cancer SQE 593-60-2 1-Oct-88
Vinyl chloride cancer LC 75-01-4 27-Feb-87 3
4-Vinylcyclohexene cancer AB 100-40-3 1-May-96
4-Vinylcyclohexene [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013 ] female, male SQE 100-40--3 7-Aug-09
4-Vinyl-1-cyclohexene diepoxide (Vinyl cyclohexenedioxide) cancer AB 106-87-6 1-Jul-90
Vinyl cyclohexene dioxide (4-Vinyl-1-cyclohexene diepoxide) [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013] female, male SQE 106-87-6 1-Aug-08
Vinyl fluoride cancer AB 75-02-5 1-May-97
Vinyl trichloride (1,1,2-Trichloroethane) cancer AB 79-00-5 1-Oct-90 10
Warfarin developmental SQE 81-81-2 1-Jul-87
Wood dust cancer LC --- 18-Dec-09
2,6-Xylidine (2,6-Dimethylaniline) cancer AB 87-62-7 1-Jan-91 110
Zalcitabine cancer LC 7481-89-2 7-Aug-09
Zidovudine (AZT) cancer LC 30516-87-1 18-Dec-09
Zileuton cancer, developmental, female FR 111406-87-2 22-Dec-00
Zineb Delisted October 29, 1999 [Click here for the basis for delisting] cancer AB 12122-67-7 1-Jan-90
 
 
 
 
Top